Flotek Industries Inc. (NYSE: FTK) has increased its full‑year 2026 financial guidance for the second time in five weeks, citing stronger-than-expected international chemistry sales. The company raised its total revenue outlook to a range of $360 million to $370 million, up from the previous $340 million to $350 million guidance issued on August 4. Adjusted EBITDA guidance was lifted to $50 million to $54 million, from the earlier $47 million to $51 million range.
At the midpoint of the new ranges, Flotek projects 2026 revenue and adjusted EBITDA to be 54% and 58% higher, respectively, than its full‑year 2025 results of approximately $240 million in revenue and $32.8 million in adjusted EBITDA.
International chemistry revenue reached about $10.6 million in the second quarter of 2026, representing a sequential increase of more than 450% from the first quarter. The company anticipates that second‑half 2026 international chemistry sales could exceed $40 million, supported by ongoing work in Saudi Arabia.
Chief Executive Officer Ryan Ezell commented, "We have continued to experience growing demand, in particular in international chemistry, since increasing our 2026 guidance last month, giving us the confidence to further increase our outlook for the year."
Flotek said it will participate in the Lake Street Annual Investor Conference in New York on Wednesday, the INVEST: Houston Leadership Summit on November 5, and the ROTH Deer Valley conference in Park City, Utah from December 9 to 11.
